SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-18-020781
Filing Date
2018-08-09
Accepted
2018-08-09 09:06:54
Documents
68
Period of Report
2018-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q apvo-10q_20180630.htm 10-Q 1804160
2 EX-10.1 apvo-ex101_214.htm EX-10.1 128876
3 EX-10.2 apvo-ex102_257.htm EX-10.2 37099
4 EX-31.1 apvo-ex311_28.htm EX-31.1 19644
5 EX-31.2 apvo-ex312_27.htm EX-31.2 19476
6 EX-32.1 apvo-ex321_25.htm EX-32.1 10290
7 EX-32.2 apvo-ex322_26.htm EX-32.2 10397
  Complete submission text file 0001564590-18-020781.txt   7034398

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT apvo-20180630.xml EX-101.INS 1598606
9 XBRL TAXONOMY EXTENSION SCHEMA apvo-20180630.xsd EX-101.SCH 50268
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE apvo-20180630_cal.xml EX-101.CAL 45299
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE apvo-20180630_def.xml EX-101.DEF 168939
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE apvo-20180630_lab.xml EX-101.LAB 352980
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE apvo-20180630_pre.xml EX-101.PRE 280480
Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Filer) CIK: 0001671584 (see all company filings)

IRS No.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37746 | Film No.: 181003646
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences